The Key Role of NIH in the Product Development Pipeline

1:00 PM - 2:15 PM, Monday, June 8, 2020 ・ Room 8
NIH has launched SEED (Small business Education and Entrepreneurial Development) to strategically align academic research resources with dedicated funding for small businesses to help entrepreneurial scientists move their promising discoveries through the early product development pipeline. For example, the NIH Phase 0 Proof of Concept consortium merges the strengths of high-impact research institutions with the expertise and resources of federal and private-sector product development partners to support innovators at 92 research institutions across 34 states and Puerto Rico. NIH’s Small Business Program, also known as America’s Seed Fund, provides over one billion dollars annually to small businesses to validate the potential healthcare potential of scientific discoveries and to test the feasibility of novel products and services resulting from these discoveries. This panel will highlight NIH’s strategic focus in early product development, resources and opportunities available to academic and small business innovators, and the ways strategic partners and investors and can partner with NIH to access novel technologies.
Moderator
photo
Federal Program Staff
NIH SEED